BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 21789021)

  • 1. An investigation into the combined effect of static magnetic fields and different anticancer drugs on K562 cell membranes.
    Liu Y; Qi H; Sun RG; Chen WF
    Tumori; 2011; 97(3):386-92. PubMed ID: 21789021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of cisplatin-procaine complex DPR with anticancer drugs increases cytotoxicity against ovarian cancer cell lines.
    Viale M; Pastrone I; Pellecchia C; Vannozzi MO; Cafaggi S; Esposito M
    Anticancer Drugs; 1998 Jun; 9(5):457-63. PubMed ID: 9660544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of a moderate-intensity static magnetic field and adriamycin on K562 cells.
    Hao Q; Wenfang C; Xia A; Qiang W; Ying L; Kun Z; Runguang S
    Bioelectromagnetics; 2011 Apr; 32(3):191-9. PubMed ID: 21365663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Static magnetic fields enhanced the potency of cisplatin on k562 cells.
    Chen WF; Qi H; Sun RG; Liu Y; Zhang K; Liu JQ
    Cancer Biother Radiopharm; 2010 Aug; 25(4):401-8. PubMed ID: 20707721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biologic effects of SMF and paclitaxel on K562 human leukemia cells.
    Sun RG; Chen WF; Qi H; Zhang K; Bu T; Liu Y; Wang SR
    Gen Physiol Biophys; 2012 Mar; 31(1):1-10. PubMed ID: 22447825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Synergistic inhibitory effect of static magnetic field and antitumor drugs on Hepa1-6 cells].
    Xu L; Guo W; Liu Y; Zhang X; Yu J; Wu W; Zhao T
    Sheng Wu Gong Cheng Xue Bao; 2015 Sep; 31(9):1363-74. PubMed ID: 26955714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effects of combinations of HER-2/neu antibody and chemotherapeutic agents used for treatment of human breast cancers.
    Pegram M; Hsu S; Lewis G; Pietras R; Beryt M; Sliwkowski M; Coombs D; Baly D; Kabbinavar F; Slamon D
    Oncogene; 1999 Apr; 18(13):2241-51. PubMed ID: 10327070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paclitaxel combination therapy in the treatment of metastatic breast cancer: a review.
    Holmes FA
    Semin Oncol; 1996 Oct; 23(5 Suppl 11):46-56. PubMed ID: 8893900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Static magnetic fields increase tumor microvessel leakiness and improve antitumoral efficacy in combination with paclitaxel.
    Gellrich D; Becker S; Strieth S
    Cancer Lett; 2014 Feb; 343(1):107-14. PubMed ID: 24075957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Static magnetic fields affect cell size, shape, orientation, and membrane surface of human glioblastoma cells, as demonstrated by electron, optic, and atomic force microscopy.
    Teodori L; Albertini MC; Uguccioni F; Falcieri E; Rocchi MB; Battistelli M; Coluzza C; Piantanida G; Bergamaschi A; Magrini A; Mucciato R; Accorsi A
    Cytometry A; 2006 Feb; 69(2):75-85. PubMed ID: 16419064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Static Magnetic Field Remotely Boosts the Efficiency of Doxorubicin through Modulating ROS Behaviors.
    Hajipour Verdom B; Abdolmaleki P; Behmanesh M
    Sci Rep; 2018 Jan; 8(1):990. PubMed ID: 29343746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased P-glycoprotein is associated with the inhibitory effects of static magnetic fields and cisplatin on K562 cells.
    Zhang K; Chen W; Bu T; Qi H; Sun R; He X
    Bioelectromagnetics; 2014 Sep; 35(6):437-43. PubMed ID: 25099308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug resistance in the treatment of sarcomas.
    Colvin OM
    Semin Oncol; 1997 Oct; 24(5):580-91. PubMed ID: 9344325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy and antiangiogenesis: drug-specific effects on microvessel sprouting.
    Albertsson P; Lennernäs B; Norrby K
    APMIS; 2003 Nov; 111(11):995-1003. PubMed ID: 14629265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of inhomogeneous static magnetic field (31.7-232.0 mT) exposure on human neuroblastoma SH-SY5Y cells during cisplatin administration.
    Vergallo C; Ahmadi M; Mobasheri H; Dini L
    PLoS One; 2014; 9(11):e113530. PubMed ID: 25423171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth inhibitory effects of trastuzumab and chemotherapeutic drugs in gastric cancer cell lines.
    Gong SJ; Jin CJ; Rha SY; Chung HC
    Cancer Lett; 2004 Oct; 214(2):215-24. PubMed ID: 15363548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alteration of the effects of cancer therapy agents on breast cancer cells by the herbal medicine black cohosh.
    Rockwell S; Liu Y; Higgins SA
    Breast Cancer Res Treat; 2005 Apr; 90(3):233-9. PubMed ID: 15830136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic drug interactions between angiogenic inhibitor, TNP-470 and anticancer agents in primary cultured hepatocytes and microsomes.
    Placidi L; Scott EC; Eckoff D; Bynon S; Sommadossi JP
    Drug Metab Dispos; 1999 May; 27(5):623-6. PubMed ID: 10220492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative in vitro cytotoxicity of taxol and Taxotere against cisplatin-sensitive and -resistant human ovarian carcinoma cell lines.
    Kelland LR; Abel G
    Cancer Chemother Pharmacol; 1992; 30(6):444-50. PubMed ID: 1356649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of static magnetic field on human leukemic cell line HL-60.
    Sabo J; Mirossay L; Horovcak L; Sarissky M; Mirossay A; Mojzis J
    Bioelectrochemistry; 2002 May; 56(1-2):227-31. PubMed ID: 12009481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.